Alternatively, the differences in purification yield observed could be due to the particular post-translational modifications of hSERCA2a, as recent heart failure research revealed that SUMOylation by SUMO-1 of hSERCA2a contributes to its stability [68]. Here, SUMO1 is linked to heart failure.